Cozad Asset Management Inc Astrazeneca PLC Transaction History

Cozad Asset Management Inc

$1.04 Billion
Q4 2024

A detailed history of Cozad Asset Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Cozad Asset Management Inc holds 34,404 shares of AZN stock, worth $2.51 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

34,404

Previous 35,910 4.19%

Holding current value

$2.51 Million

Previous $2.8 Million 19.44%

% of portfolio

0.22%

Previous 0.27%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$63.2 - $79.58 $95,179 - $119,847	-1,506 Reduced 4.19%	34,404 $2.25 Million
Q3 2024 Oct 31, 2024	SELL	$76.67 - $87.62 $383,350 - $438,100	-5,000 Reduced 12.22%	35,910 $2.8 Million
Q2 2024 Aug 02, 2024	BUY	$66.81 - $80.83 $561,204 - $678,972	8,400 Added 25.84%	40,910 $3.19 Million
Q1 2024 May 08, 2024	BUY	$61.03 - $69.57 $15,928 - $18,157	261 Added 0.81%	32,510 $2.2 Million
Q4 2023 Feb 05, 2024	BUY	$61.89 - $69.28 $337,300 - $377,576	5,450 Added 20.34%	32,249 $2.17 Million
Q3 2023 Nov 02, 2023	BUY	$64.85 - $71.7 $298,245 - $329,748	4,599 Added 20.72%	26,799 $1.81 Million
Q2 2023 Jul 26, 2023	BUY	$69.91 - $75.81 $73,335 - $79,524	1,049 Added 4.96%	22,200 $1.59 Million
Q1 2023 May 01, 2023	BUY	$63.15 - $71.6 $267,124 - $302,868	4,230 Added 25.0%	21,151 $1.47 Million
Q4 2022 Feb 07, 2023	BUY	$54.21 - $70.44 $464,904 - $604,093	8,576 Added 102.77%	16,921 $1.15 Million
Q3 2022 Nov 07, 2022	BUY	$53.02 - $135.75 $43,317 - $110,907	817 Added 10.85%	8,345 $458,000
Q3 2021 Nov 05, 2021	BUY	$55.56 - $60.79 $3,833 - $4,194	69 Added 0.93%	7,528 $452,000
Q2 2021 Jul 29, 2021	SELL	$48.42 - $60.18 $106,039 - $131,794	-2,190 Reduced 22.7%	7,459 $447,000
Q1 2021 Apr 29, 2021	BUY	$47.16 - $54.44 $14,147 - $16,332	300 Added 3.21%	9,649 $480,000
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $8,879 - $10,617	-183 Reduced 1.92%	9,349 $467,000
Q3 2020 Oct 28, 2020	BUY	$53.07 - $61.1 $57,262 - $65,926	1,079 Added 12.76%	9,532 $522,000
Q2 2020 Aug 07, 2020	SELL	$43.1 - $55.31 $108,267 - $138,938	-2,512 Reduced 22.91%	8,453 $447,000
Q1 2020 May 07, 2020	SELL	$37.79 - $51.33 $16,249 - $22,071	-430 Reduced 3.77%	10,965 $490,000
Q4 2019 Jan 16, 2020	SELL	$42.46 - $50.46 $13,162 - $15,642	-310 Reduced 2.65%	11,395 $568,000
Q3 2019 Oct 31, 2019	BUY	$40.12 - $45.47 $12,838 - $14,550	320 Added 2.81%	11,705 $522,000
Q2 2019 Aug 13, 2019	SELL	$37.28 - $41.68 $5,778 - $6,460	-155 Reduced 1.34%	11,385 $470,000
Q1 2019 Apr 18, 2019	SELL	$35.49 - $43.02 $14,196 - $17,208	-400 Reduced 3.35%	11,540 $467,000
Q4 2018 Jan 14, 2019	BUY	$36.86 - $41.49 $1,769 - $1,991	48 Added 0.4%	11,940 $453,000
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $16,684 - $19,065	-480 Reduced 3.88%	11,892 $471,000
Q2 2018 Aug 15, 2018	BUY	$34.55 - $37.05 $427,452 - $458,382	12,372 New	12,372 $434,000

Others Institutions Holding AZN

# of Institutions

1,368

Shares Held

475M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $226B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cozad Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cozad Asset Management Inc with notifications on news.

Account

Cozad Asset Management Inc Astrazeneca PLC Transaction History